Sequestration of Polo Kinase to Microtubules by Phosphopriming-Independent Binding to Map205 Is Relieved by Phosphorylation at a CDK Site in Mitosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cell Type–Dependent Effects of Polo-Like Kinase 1 Inhibition Compared with Targeted Polo Box Interference in Cancer Cell Lines
3189 Cell type–dependent effects of Polo-like kinase 1 inhibition compared with targeted polo box interference in cancer cell lines Jenny Fink, Karl Sanders, Alexandra Rippl, certain cell lines but highly contrasting effects in others. Sylvia Finkernagel, Thomas L. Beckers, This may point to subtle differences in the molecular and Mathias Schmidt machinery of mitosis regulation in cancer cells. [Mol Cancer Ther 2007;6(12):3189–97] Nycomed GmbH, Konstanz, Germany Introduction Abstract Polo-like kinase 1 (Plk1) has been identified as key player Multiple critical roles within mitosis have been assigned for G2-M transition and mitotic progression in both normal to Polo-like kinase 1 (Plk1), making it an attractive and tumor cells (1). Multiple roles have been assigned to candidate for mitotic targeting of cancer cells. Plk1 Plk1 at the entry into M phase, mitotic spindle formation, contains two domains amenable for targeted interference: condensation and separation of chromosomes, exit from a kinase domain responsible for the enzymatic function mitosis by activation of the anaphase-promoting complex, and a polo box domain necessary for substrate recogni- and in cytokinesis (reviewed in ref. 2). Moreover, recent tion and subcellular localization. Here, we compare two reports implicated an involvement of Plk1 in the resump- approaches for targeted interference with Plk1 function, tion of cell cycle reentry after checkpoint activation through either by a Plk1 small-molecule enzyme inhibitor or by DNA-damaging agents (3). It is therefore not surprising inducible overexpression of the polo box in human cancer that targeted interference with Plk1, primarily by anti- cell lines. -
Review Article Mitotic Kinases and P53 Signaling
Hindawi Publishing Corporation Biochemistry Research International Volume 2012, Article ID 195903, 14 pages doi:10.1155/2012/195903 Review Article Mitotic Kinases and p53 Signaling Geun-Hyoung Ha1 and Eun-Kyoung Yim Breuer1, 2 1 Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA 2 Department of Molecular Pharmacology and Therapeutics, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA Correspondence should be addressed to Eun-Kyoung Yim Breuer, [email protected] Received 6 April 2012; Accepted 18 May 2012 Academic Editor: Mandi M. Murph Copyright © 2012 G.-H. Ha and E.-K. Y. Breuer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Mitosis is tightly regulated and any errors in this process often lead to aneuploidy, genomic instability, and tumorigenesis. Deregulation of mitotic kinases is significantly associated with improper cell division and aneuploidy. Because of their importance during mitosis and the relevance to cancer, mitotic kinase signaling has been extensively studied over the past few decades and, as a result, several mitotic kinase inhibitors have been developed. Despite promising preclinical results, targeting mitotic kinases for cancer therapy faces numerous challenges, including safety and patient selection issues. Therefore, there is an urgent need to better understand the molecular mechanisms underlying mitotic kinase signaling and its interactive network. Increasing evidence suggests that tumor suppressor p53 functions at the center of the mitotic kinase signaling network. In response to mitotic spindle damage, multiple mitotic kinases phosphorylate p53 to either activate or deactivate p53-mediated signaling. -
Α-Synuclein-Sy-Synucleinnuclein Phosphorylationphosphorylation Andand Re Relatedlated Kinaseskinases Inin Parkinsonparkinson’S Diseasedisease
αα-Synuclein-Sy-Synucleinnuclein phosphorylationphosphorylation andand relatedrelated kinaseskinases inin ParkinsonParkinson’s diseasedisease Jin-XiaJin-Xia ZhouZhou A thesis submitted in fulfillment of the requirement of the degree of Doctor of Philosophy School of Medical Sciences, Faculty of Medicine and Neuroscience Research Australia November 2013 I PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Zhou First name: Jin-Xia Other name/s: I Abbreviation for degree as given in the University calendar: PhD School: School of Medical Sciences Faculty: Medicine lation and related kinases in Parkinson's disease Abstract 350 words maximum: (PLEASE TYPE) ' Parkinson's disease (PO) is the most common neurodegenerative movement disorder pathologically identified by degeneration of the nigrostriatal system and the presence of Lcwy bodies (LBs) and neurites. structuTal pathologies largely made from insoluble a-synuclein phosphorylated at serine 129 (S 129P). Several kinases have been suggested to facilitate a-synuciein phosphorylation in PD, but without significant human data the changes that precipitate such pathology remain conjecture. The major aims of this pr~ject were to assess the dynamic changes of a -synuclein phosphorylation and related kinases in the progression of PD and in animal models of PD. and to determine whether Tenuigenin (TEN), a Chinese medicinal herb, can prevent cc-synucleln-induc.?d toxicity in a cell model. The levels of non-phosphorylated a-synuclein decreased over the course ofPD, becoming increasingly phosphorylated and insoluble. There was a dramatic increase in phosphorylated a-synuclein that preceded LB formation. Importantly, three a-synuc!ein-relatec ki nases [polo-like kinase 2 {PLK2), lcuc.:inc- rich repeat kinase 2 (LRRK2l and cyclin G-~tssoc i ated kinase (GAK)] were found to be involved at different times in the evolution of LB formation in P.O. -
PLK-1 Promotes the Merger of the Parental Genome Into A
RESEARCH ARTICLE PLK-1 promotes the merger of the parental genome into a single nucleus by triggering lamina disassembly Griselda Velez-Aguilera1, Sylvia Nkombo Nkoula1, Batool Ossareh-Nazari1, Jana Link2, Dimitra Paouneskou2, Lucie Van Hove1, Nicolas Joly1, Nicolas Tavernier1, Jean-Marc Verbavatz3, Verena Jantsch2, Lionel Pintard1* 1Programme Equipe Labe´llise´e Ligue Contre le Cancer - Team Cell Cycle & Development - Universite´ de Paris, CNRS, Institut Jacques Monod, Paris, France; 2Department of Chromosome Biology, Max Perutz Laboratories, University of Vienna, Vienna Biocenter, Vienna, Austria; 3Universite´ de Paris, CNRS, Institut Jacques Monod, Paris, France Abstract Life of sexually reproducing organisms starts with the fusion of the haploid egg and sperm gametes to form the genome of a new diploid organism. Using the newly fertilized Caenorhabditis elegans zygote, we show that the mitotic Polo-like kinase PLK-1 phosphorylates the lamin LMN-1 to promote timely lamina disassembly and subsequent merging of the parental genomes into a single nucleus after mitosis. Expression of non-phosphorylatable versions of LMN- 1, which affect lamina depolymerization during mitosis, is sufficient to prevent the mixing of the parental chromosomes into a single nucleus in daughter cells. Finally, we recapitulate lamina depolymerization by PLK-1 in vitro demonstrating that LMN-1 is a direct PLK-1 target. Our findings indicate that the timely removal of lamin is essential for the merging of parental chromosomes at the beginning of life in C. elegans and possibly also in humans, where a defect in this process might be fatal for embryo development. *For correspondence: [email protected] Introduction Competing interests: The After fertilization, the haploid gametes of the egg and sperm have to come together to form the authors declare that no genome of a new diploid organism. -
In Situ Detection of Protein Interactions for Recombinant Therapeutic Enzymes
In situ detection of protein interactions for recombinant therapeutic enzymes Mojtaba Samoudi1, Chih-Chung Kuo1, Caressa Robinson1, Km Shams-Ud-Doha2, Song-Min Schinn1, Stefan Kol3, Linus Weiss4, Sara Petersen Bjørn5, Bjørn Voldborg5, Alexandre Rosa Campos2, and Nathan Lewis6 1University of California San Diego 2Sanford Burnham Prebys Medical Discovery Institute 3Technical University of Denmark 4Eberhard Karls University T¨ubingen 5DTU Biosustain 6University of California, San Diego May 15, 2020 Abstract Despite their therapeutic potential, many protein drugs remain inaccessible to patients since they are difficult to secrete. Each recombinant protein has unique physicochemical properties and requires different machinery for proper folding, assembly, and post-translational modifications (PTMs). Here we aimed to identify the machinery supporting recombinant protein secretion by measuring the protein-protein interaction (PPI) networks of four different recombinant proteins (SERPINA1, SERPINC1, SERPING1 and SeAP) with various PTMs and structural motifs using the proximity-dependent biotin identification (BioID) method. We identified PPIs associated with specific features of the secreted proteins using a Bayesian statistical model, and found proteins involved in protein folding, disulfide bond formation and N-glycosylation were positively correlated with the corresponding features of the four model proteins. Among others, oxidative folding enzymes showed the strongest association with disulfide bond formation, supporting their critical roles in proper folding and maintaining the ER stability. Knock down of ERP44, a measured interactor with the highest fold change, led to the decreased secretion of SERPINC1, which relies on its extensive disulfide bonds. Proximity-dependent labeling successfully identified the transient interactions supporting synthesis of secreted recombinant proteins and refined our understanding of key molecular mechanisms of the secretory pathway during recombinant protein production. -
Structures, Functions, and Mechanisms of Filament Forming Enzymes: a Renaissance of Enzyme Filamentation
Structures, Functions, and Mechanisms of Filament Forming Enzymes: A Renaissance of Enzyme Filamentation A Review By Chad K. Park & Nancy C. Horton Department of Molecular and Cellular Biology University of Arizona Tucson, AZ 85721 N. C. Horton ([email protected], ORCID: 0000-0003-2710-8284) C. K. Park ([email protected], ORCID: 0000-0003-1089-9091) Keywords: Enzyme, Regulation, DNA binding, Nuclease, Run-On Oligomerization, self-association 1 Abstract Filament formation by non-cytoskeletal enzymes has been known for decades, yet only relatively recently has its wide-spread role in enzyme regulation and biology come to be appreciated. This comprehensive review summarizes what is known for each enzyme confirmed to form filamentous structures in vitro, and for the many that are known only to form large self-assemblies within cells. For some enzymes, studies describing both the in vitro filamentous structures and cellular self-assembly formation are also known and described. Special attention is paid to the detailed structures of each type of enzyme filament, as well as the roles the structures play in enzyme regulation and in biology. Where it is known or hypothesized, the advantages conferred by enzyme filamentation are reviewed. Finally, the similarities, differences, and comparison to the SgrAI system are also highlighted. 2 Contents INTRODUCTION…………………………………………………………..4 STRUCTURALLY CHARACTERIZED ENZYME FILAMENTS…….5 Acetyl CoA Carboxylase (ACC)……………………………………………………………………5 Phosphofructokinase (PFK)……………………………………………………………………….6 -
Mtor REGULATES AURORA a VIA ENHANCING PROTEIN STABILITY
mTOR REGULATES AURORA A VIA ENHANCING PROTEIN STABILITY Li Fan Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Doctor of Philosophy in the Department of Biochemistry and Molecular Biology, Indiana University December 2013 Accepted by the Graduate Faculty, of Indiana University, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. Lawrence A. Quilliam, Ph.D., Chair Doctoral Committee Simon J. Atkinson, Ph.D. Mark G. Goebl, Ph.D. October 22, 2013 Maureen A. Harrington, Ph.D. Ronald C. Wek, Ph.D. ii © 2013 Li Fan iii DEDICATION I dedicate this thesis to my family: to my parents, Xiu Zhu Fan and Shu Qin Yang, who have been loving, supporting, and encouraging me from the beginning of my life; to my husband Fei Huang, who provided unconditional support and encouragement through these years; to my son, David Yan Huang, who has made my life highly enjoyable and meaningful. iv ACKNOWLEDGMENTS I sincerely thank my mentor Dr. Lawrence Quilliam for his guidance, motivation, support, and encouragement during my dissertation work. His passion for science and the scientific and organizational skills I have learned from Dr. Quilliam made it possible for me to achieve this accomplishment. Many thanks to Drs. Ron Wek, Mark Goebl, Maureen Harrington, and Simon Atkinson for serving on my committee and providing constructive suggestions and technical advice during my Ph.D. program. I have had a pleasurable experience working with all the people in our laboratory. Thanks Drs. Justin Babcock and Sirisha Asuri, and Mr. -
Distinct C-Terminal Amino Acid Sequence Motifs Serve As the Targeting Signals for Outer Mitochondrial Membrane and Plastid Outer Envelope TA Proteins
Distinct C-terminal Amino Acid Sequence Motifs Serve as the Targeting Signals for Outer Mitochondrial Membrane and Plastid Outer Envelope TA Proteins by Howard James Teresinski A Thesis presented to The University of Guelph In partial fulfilment of requirements for the degree of Master of Science in Molecular and cellular Biology Guelph, Ontario, Canada © Howard James Teresinski, January, 2015 ABSTRACT Distinct C-terminal amino acid sequence motifs serve as the targeting signals for outer mitochondrial membrane and plastid outer envelope TA proteins Howard James Teresinski Advisor: University of Guelph, 2014 Dr. Robert T. Mullen Tail-anchored (TA) proteins are a unique class of functionally diverse membrane proteins that are defined by their single C-terminal transmembrane domain and their ability to insert post-translationally into specific organelles in an Ncytosol-CIMS orientation. While in recent years considerable progress has been made towards understanding the biogenesis of TA proteins in yeast and mammals, relatively little is known about how these proteins are properly partitioned within plant cells, mostly because so few plant TA proteins have been identified. Here we show the results of experiments aimed at cataloguing, in silico, all of the TA outer mitochondrial membrane and plastid outer envelope proteins in Arabidopsis and then identifying and characterising distinct, C-terminal targeting motifs responsible for the proper sorting of at least a subset of these proteins. Collectively, the results of this thesis provide important insight into the molecular mechanisms that underlie the biogenesis of TA proteins in plant cells. Acknowledgments I would first and foremost like to thank my MSc advisor Dr. -
And Integrin-Binding Protein CIB
376 Vol. 1, 376–384, March 2003 Molecular Cancer Research The Serum-Inducible Protein Kinase Snk Is a G1 Phase Polo-Like Kinase That Is Inhibited by the Calcium- and Integrin-Binding Protein CIB Sheng Ma,1 Mei-Ann Liu,1,2 Yi-Lu O. Yuan,1,3 and Raymond L. Erikson1 Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA Abstract cytokinesis. The Xenopus Plx1 activates Cdc2 indirectly by Identified as an immediate-early transcript, the serum- phosphorylation and activation of Cdc25C (2–4). Plx1 and inducible kinase Snk bears sequence homology with the Plk1 have been reported to be involve in nuclear translocation polo-like kinases. Endogenous Snk was detected in of cyclin B1 (5), but a recent report argued that phosphorylation early G1 in NIH 3T3 cells, and nascent Snk showed a half- by Plk1 does not cause cyclin B1 to move into the nucleus (6). life of about 15 min. The kinase activity of endogenous Mitotic Plks also appear to contribute to centrosome matura- Snk was detected in G1. Substitution of Thr-236 with a tion, disintegration of the Golgi apparatus in mitosis (7–9), glutamate residue increased Snk kinase activity by formation of bipolar spindles (3, 10, 11), regulation of the about 10-fold, whereas substitution of Lys-108 abolished anaphase-promoting complex (APC) (12–15), separation of the its kinase activity. Disrupting the polo-box did not sister chromatids (16), and completion of cytokinesis (17–21). significantly change Snk kinase activity. A GFP-C-Snk A role in regulating DNA replication was reported for the fusion protein showed polo-box-dependent localization budding yeast CDC5 (22). -
And Multiple Conformations Kinase 4 Structures Reveal Novel Features Cutting Edge: IL-1 Receptor-Associated
Cutting Edge: IL-1 Receptor-Associated Kinase 4 Structures Reveal Novel Features and Multiple Conformations This information is current as Andreas Kuglstatter, Armando G. Villaseñor, David Shaw, of September 23, 2021. Simon W. Lee, Stan Tsing, Linghao Niu, Kyung W. Song, Jim W. Barnett and Michelle F. Browner J Immunol 2007; 178:2641-2645; ; doi: 10.4049/jimmunol.178.5.2641 http://www.jimmunol.org/content/178/5/2641 Downloaded from References This article cites 23 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/178/5/2641.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. THE JOURNAL OF IMMUNOLOGY CUTTING EDGE Cutting Edge: IL-1 Receptor-Associated Kinase 4 Structures Reveal Novel Features and Multiple Conformations Andreas Kuglstatter,1 Armando G. Villasen˜or, David Shaw, Simon W. -
Torin1-Mediated TOR Kinase Inhibition Reduces Wee1 Levels And
ß 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 1346–1356 doi:10.1242/jcs.146373 RESEARCH ARTICLE Torin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cells Jane Atkin1, Lenka Halova1, Jennifer Ferguson1, James R. Hitchin2, Agata Lichawska-Cieslar3, Allan M. Jordan2, Jonathon Pines3, Claudia Wellbrock1 and Janni Petersen1,* ABSTRACT target the kinase domain of mTOR, such as Torin1 (Thoreen et al., 2009), mimics the impact of rapamycin treatment in The target of rapamycin (TOR) kinase regulates cell growth and budding yeast, in that they induce autophagy, reduce protein division. Rapamycin only inhibits a subset of TOR activities. Here we synthesis and arrest cell cycle progression in G1 with a reduced show that in contrast to the mild impact of rapamycin on cell division, cell size (Thoreen et al., 2009). These effects of Torin1 blocking the catalytic site of TOR with the Torin1 inhibitor completely established that there are rapamycin-resistant roles for arrests growth without cell death in Schizosaccharomyces pombe.A mTORC1 that are essential for growth and proliferation. Torin1 mutation of the Tor2 glycine residue (G2040D) that lies adjacent to interacts with tryptophan-2239 in the catalytic, active site of the key Torin-interacting tryptophan provides Torin1 resistance, mTOR kinase (Yang et al., 2013). Crucially, this residue is absent confirming the specificity of Torin1 for TOR. Using this mutation, we in other kinases, including the mTOR-related phosphoinositide 3- show that Torin1 advanced mitotic onset before inducing growth kinases (PI3Ks). arrest. In contrast to TOR inhibition with rapamycin, regulation by Here, we describe the isolation of a tor2 mutation that maps to either Wee1 or Cdc25 was sufficient for this Torin1-induced advanced a conserved glycine located next to the key tryptophan (W2239 of mitosis. -
Downloaded for Personal Non-Commercial Research Or Study, Without Prior Permission Or Charge
https://theses.gla.ac.uk/ Theses Digitisation: https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ This is a digitised version of the original print thesis. Copyright and moral rights for this work are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This work cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Enlighten: Theses https://theses.gla.ac.uk/ [email protected] Anion And Cation Binding In Proteins James David Watson Submitted for the degree of Doctor of Philosophy The University of Glasgow Faculty of IBLS September 2002 ProQuest Number: 10390636 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10390636 Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLO. ProQuest LLO. 789 East Eisenhower Parkway P.Q.